Brief Reviews |
From the Division of Cardiovascular Medicine (J.H.F.R.), Cambridge University, UK; Department of Cardiology and Nuclear Medicine (F.H.), Bichat Hospital, Assistance Publique-Hopitaux de Paris and Institut National de la Santé et de la Recherche Medicalé U698, Paris, France; and Translational and Molecular Imaging Institute (Z.A.F.), Mount Sinai School of Medicine, New York, New York.
Correspondence to Dr. James H.F. Rudd, Division of Cardiovascular Medicine, Cambridge University, UK, E-mail jhfr2{at}cam.ac.uk or Professor Zahi A. Fayad, Translational and Molecular Imaging Institute, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, E-mail Zahi.fayad@maam.edu.
Series Editor: Zahi Fayad
ATVB In Focus
Molecular Imaging of Cardiovascular Disease
Inflammation is important at many stages of atherosclerotic plaque development. We highlight several imaging modalities that can quantify the degree of plaque inflammation noninvasively. Imaging of this type might allow testing of novel antiatherosclerosis drugs, identification of patients at risk of plaque rupture, and deeper insight into the biology of the disease. The imaging modalities are discussed in relation to their potential use in these areas.
Key Words: pathophysiology imaging computed tomography and magnetic resonance imaging nuclear cardiology and positron-emission tomography cardiovascular imaging agents/techniques
This article has been cited by other articles:
![]() |
Z. A. Fayad Cardiovascular Molecular Imaging Arterioscler Thromb Vasc Biol, July 1, 2009; 29(7): 981 - 982. [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2009 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |